List of insiders holdings for Assertio Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Molinelli Gavin Director | 2017-03-30 21:03:21 | 29,268 5,295,271 | 5,324,539 | Form 4 |
TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC 10% Owner | 2013-02-14 08:06:45 | 2,475,016 0 | 2,475,016 | Form 13G |
BIOVAIL LABORATORIES INC 10% Owner | 2008-09-19 11:02:36 | 2,364,987 0 | 2,364,987 | Form 13D |
CALLAGHAN MICHAEL J Director | 2004-03-09 13:41:28 | 0 2,181,412 | 2,181,412 | Form 4 |
HIGGINS ARTHUR J Director, President and CEO | 2020-02-12 18:41:18 | 439,564 178,000 | 617,564 | Form 4 |
Schoeneck James A President and CEO | 2017-02-10 19:40:47 | 0 495,105 | 495,105 | Form 5 |
STAPLE PETER D Director | 2019-11-12 16:36:48 | 207,880 13,900 | 221,780 | Form 4 |
HAMILTON JOHN F VP & CFO | 2007-10-12 18:15:02 | 205,644 0 | 205,644 | Form 4 |
Peisert Daniel A. SVP and CFO | 2020-02-12 18:41:39 | 158,383 0 | 158,383 | Form 4 |
Wheadon David E. Director | 2019-10-01 17:15:53 | 145,038 0 | 145,038 | Form 4 |
FOGARTY JAMES P Director | 2019-05-09 11:28:57 | 106,796 0 | 106,796 | Form 4 |
Bukofzer Stan SVP, Chf Scitfc & Tech Officer | 2020-04-03 19:54:36 | 103,500 0 | 103,500 | Form 4/A |
Pelzel Carl A President and CEO | 2011-01-14 17:11:52 | 100,000 0 | 100,000 | Form 4 |
Zenoff David B Director | 2017-02-23 19:03:16 | 0 93,999 | 93,999 | Form 4 |
Donenberg Phillip B. SVP and CFO | 2018-07-16 16:10:12 | 87,163 0 | 87,163 | Form 4 |
DAWES KAREN A Director | 2020-05-11 20:23:47 | 84,589 0 | 84,589 | Form 4 |
BERNER BRET VP & CSO | 2006-02-14 13:14:26 | 84,000 0 | 84,000 | Form 4 |
Tyree James L Director | 2019-05-09 11:31:07 | 80,590 0 | 80,590 | Form 4 |
Moretti August J Chief Financial Officer & SVP | 2018-04-03 20:35:22 | 74,447 0 | 74,447 | Form 4 |
MCKEE WILLIAM Director | 2019-05-09 18:26:24 | 67,846 0 | 67,846 | Form 4 |
LAVIGNE LOUIS J JR Director | 2019-05-09 11:29:36 | 58,296 0 | 58,296 | Form 4 |
Mason Heather L Director | 2020-02-19 17:00:01 | 43,182 0 | 43,182 | Form 4 |
Cameron Tammy VP, Finance | 2011-09-02 17:05:35 | 37,500 0 | 37,500 | Form 4 |
Galeota James JR Director | 2020-03-31 19:32:06 | 37,475 0 | 37,475 | Form 4 |
Vetticaden Santosh SVP, Chief Medical Officer *** | 2018-02-08 20:14:35 | 36,800 0 | 36,800 | Form 4 |
BURRILL STEVEN Director | 2013-12-12 15:10:18 | 20,000 0 | 20,000 | Form 4 |
SMITH CRAIG R Director | 2012-12-06 20:23:44 | 20,000 0 | 20,000 | Form 4 |
STERN JULIAN N Director | 2012-12-06 20:21:59 | 20,000 0 | 20,000 | Form 4 |
Srinivas G. Rao SVP and Chief Medical Officer | 2017-04-04 20:00:50 | 19,527 0 | 19,527 | Form 4 |
Savage Robert G. Director | 2016-10-19 18:25:37 | 18,485 0 | 18,485 | Form 4 |
THOMPSON W LEIGH MD PHD Director | 2003-12-22 14:14:55 | 15,000 0 | 15,000 | Form 4 |
SHELL JOHN W Director | 2006-12-07 14:45:49 | 15,000 0 | 15,000 | Form 4 |
FARA JOHN W Director | 2007-12-07 16:55:05 | 15,000 0 | 15,000 | Form 4 |
Saks Samuel R Director | 2016-05-20 19:05:50 | 10,800 0 | 10,800 | Form 4 |
SHELL JOHN N VP, Operations | 2008-01-29 19:41:52 | 10,000 0 | 10,000 | Form 4 |
Sweeney Michael MD CMO and VP, R&D | 2013-12-04 16:50:56 | 9,084 0 | 9,084 | Form 4 |
PROEHL GERALD T Director | 2006-03-27 14:24:36 | 5,000 0 | 5,000 | Form 4 |
ANIDO VICENTE JR Director | 2016-05-13 18:41:22 | 4,403 0 | 4,403 | Form 4 |
Shively Richard Scott SVP & Chief Commercial Officer | 2016-04-05 21:15:41 | 4,290 0 | 4,290 | Form 4 |
Gosling Matthew M SVP, General Counsel | 2018-05-15 18:15:41 | 0 0 | 0 | Form 4 |
Vargas Thadd M SVP, Business Development | 2017-06-15 16:43:36 | 0 0 | 0 | Form 4 |